Clinical and Translational Oncology
-
Publication Venue For
- Combination of DC/CIK adoptive T cell immunotherapy with chemotherapy in advanced non-small-cell lung cancer (NSCLC) patients: a prospective patients' preference-based study (PPPS). 2018
- Biological function and mechanism of miR-33a in prostate cancer survival and metastasis: via downregulating Engrailed-2.. 19:562-570. 2017
- Prospective study of cyclophosphamide, thiotepa, carboplatin combined with adoptive DC-CIK followed by metronomic cyclophosphamide therapy as salvage treatment for triple negative metastatic breast cancers patients (aged <45).. 18:82-87. 2016
- PEG1/MEST and IGF2 DNA methylation in CIN and in cervical cancer. 16:266-272. 2014
- PEG1/MEST and IGF2 DNA methylation in CIN and in cervical cancer.. 16:266-272. 2014
- PEG1/MEST and IGF2 DNA methylation in CIN and in cervical cancer. 16:266-272. 2014
- Selections of appropriate regimen of high-dose chemotherapy combined with adoptive cellular therapy with dendritic and cytokine-induced killer cells improved progression-free and overall survival in patients with metastatic breast cancer: reargument of such contentious therapeutic preferences.. 15:780-788. 2013
- Specific genetic polymorphisms of IL10-592 AA and IL10-819 TT genotypes lead to the key role for inducing docetaxel-induced liver injury in breast cancer patients.. 15:331-334. 2013
- Murine bone marrow stromal cells pulsed with homologous tumor-derived exosomes inhibit proliferation of liver cancer cells.. 14:764-773. 2012
- Clinical safety of induced CTL infusion through recombinant adeno-associated virus-transfected dendritic cell vaccination in Chinese cancer patients. 14:675-681. 2012
- Recombinant human endostatin could eliminate the pro-angiogenesis priority of SP cells sorted from non-small cell lung cancer cells.. 14:575-585. 2012
- Damage assessment in gastric cancer treatment with adjuvant radiochemotherapy: calculation of the NTCP's from the differential HDV of the organs at risk.. 8:271-278. 2006